
ConcertAI strikes five-year collaboration with FDA as part of real-world evidence push
The startup will work with the FDA to evaluate the efficacy and safety of current cancer treatments in different groups of cancer patients.
The startup will work with the FDA to evaluate the efficacy and safety of current cancer treatments in different groups of cancer patients.